Translational Research: Target Identification
One of the first steps in discovering a new therapeutic is identifying a specific molecular target or phenotypic readout for which there is sufficient evidence that it plays a key role in disease progression or symptomology. This may involve approaches utilizing transgenic animals, monitoring signal transduction networks in ex vivo human samples, or genetic studies.
- 
                
                
                Disease
 Biology
- 
                Unvalidated
 TargetTarget IDPutative
 Targets
- 
                
                Nominated
 TargetAssay DevelopmentScreenable
 Assays
- 
                
                Target AssayScreeningHits and
 Starting Points
- 
                
                HitHit to LeadLead Series
- 
                
                Lead
 CompoundLead
 OptimizationPotential
 Therapeutic
 Leads
- 
                
                Pre‑clinical
 CandidatePre‑clinical
 DevelopmentClinical
 Therapeutic
 Candidate
- 
                
                Clinical
 CandidateClinical
 DevelopmentClinical Proof
 of Concept
- 
                Licensing and
 Commercializa-
 tion PartnersMarket-ready
 Therapeutics
NIH Funding Opportunities
- PA-20-185, NIH Research Project Grant
- PAR-22-171, NIDDK Central Repositories Non-renewable Sample Access (X01)
- See NIDDK Current Funding Opportunities or the NIH Guide for Grants and Contracts for more information on active funding opportunities to support basic research on disease biology
- Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)
Related Resources
- NIDDK Central Repository
- Active Basic and Clinical Research Networks
- Type 2 Diabetes Knowledge Portal
- Illuminating the Druggable Genome
- PHAROS
Staff Contacts
Division of Kidney, Urologic, and Hematologic Diseases
Dr. Anna Sadusky
Division of Digestive Diseases and Nutrition
Dr. Bonnie Burgess-Beusse
Division of Diabetes, Endocrinology, and Metabolic Diseases
Dr. Yan Li
For disease area expertise, review the Research Programs and Contacts page.